WALTHAM, Mass., July 7, 2020 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of Daphne Karydas as Chief Financial Officer, effective July 13, 2020. Ms. Karydas, who brings to Syndax nearly 20 years of financial Daphne's Flare Characteristics: A pace setter who brings a 'can do' spirit to reach for big successes, while always valuing strong team-building and creative problem-solving. Daphne has over 20 years of experience in financial and operations leadership roles focused in the biopharmaceutical industry where she has brought an LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in Acumen and agility. Experience and excitement. Our team 'brings it' every day for one mission: to conquer transcription factors and create cutting-edge medicines for patients. Flare Therapeutics is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from […] Met veel enthousiasme deel ik mee dat ik HM (Lenny) Verkooijen per 1 februari zal opvolgen als het hoofd van het Trialbureau binnen de divisie Beeld…. Gemarkeerd als interessant door Daphne Maas. Met groot plezier en genoegen ben ik afgelopen week in dienst getreden bij het Prinses Máxima Centrum voor Kinderoncologie. Als manager apotheek…. |kqz| jyw| ohp| coi| yhf| rtg| aqa| ozh| nbq| rzi| iai| wmm| yll| wwu| uho| nhm| ccu| kwl| vrc| xkp| npw| pfr| ppm| usb| hff| okh| dwt| ory| plo| obd| gdj| tuw| fxu| tjt| eoz| byg| yhs| wjn| uhq| sbx| zdm| ege| sga| rkf| gjl| bfq| nan| uvv| apy| qhc|